Data / Form D filings / SEELOS THERAPEUTICS, INC.
SEELOS THERAPEUTICS, INC.: Form D filings
SEELOS THERAPEUTICS, INC., a biotechnology company in New York, NY, filed 9 Form D notices with the SEC between 2010 and 2024. The latest, on July 30, 2024, reports an offering of $1.1 million with nothing sold yet to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 PARK AVENUE, 2ND FLOOR, New York, NY, 10022
- Phone
- (646) 293-2100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1017491
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | New notice | $1,146,481 | $0 | $1,146,481 | 3 | Jul 11, 2024 | sec.gov |
| May 31, 2024 | New notice | $2,042,954 | $0 | $2,042,954 | 2 | May 21, 2024 | sec.gov |
| Feb 14, 2024 | New notice | $3,574,468 | $0 | $3,574,468 | 3 | Jan 30, 2024 | sec.gov |
| Sep 14, 2020 | New notice | $5,584,950 | $0 | $5,584,950 | 13 | Sep 9, 2020 | sec.gov |
| Aug 30, 2019 | New notice | $3,982,750 | $0 | $3,982,750 | 9 | Aug 27, 2019 | sec.gov |
| Sep 27, 2017 | New notice | $3,691,000 | $3,691,000 | 9 | Sep 13, 2017 | sec.gov | |
| Oct 13, 2016 | New notice | $3,653,106 | $3,653,106 | 2 | Sep 28, 2016 | sec.gov | |
| Mar 18, 2010 | New notice | $4,000,000 | $4,000,000 | 3 | Mar 15, 2010 | sec.gov | |
| Mar 10, 2010 | New notice | $2,500,000 | $2,300,000 | $200,000 | 3 | Feb 4, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Raj Mehra | Executive Officer | |
| Brian Lian | Director | |
| Margaret W. Dalesandro | Director | |
| Michael W. Golembiewski | Executive Officer | |
| Richard W. Pascoe | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jul 29, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SEELOS THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.